ARMP Operating Cash Flow Growth
Armata Pharmaceuticals, Inc. Common Stock · Operating Cash Flow Growth
ARMP Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported19.51%period ending
ARMP TTM Cash from Operations YoY % (-16.05% → 19.51%)
Year-over-year change
High-resolution chart · PNG
ARMP operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 19.5086% | |
| 30.6307% | |
| 31.392% | |
| 28.3965% | |
| 18.0863% | |
| 14.5659% | |
| 20.8169% | |
| 24.24% | |
| 23.5768% | |
| 13.106% | |
| -46.0023% | |
| -62.7836% | |
| -99.9921% | |
| -115.2949% | |
| -37.7773% | |
| -43.7756% | |
| -24.9072% | |
| -10.7723% | |
| -29.0367% | |
| -44.7846% | |
| -31.2728% | |
| -13.4873% | |
| -17.2507% | |
| 3.8217% | |
| -28.6395% | |
| -103.0947% | |
| -66.084% | |
| -63.9065% | |
| -37.9195% | |
| 10.2132% | |
| -2.067% | |
| -12.2712% | |
| 20.024% | |
| 12.7187% | |
| 13.1929% | |
| 27.3173% | |
| -0.4726% | |
| -2.2914% | |
| -8.2609% | |
| -7.0859% | |
| 0.2127% | |
| 5.6211% | |
| 22.2001% | |
| 10.6075% | |
| 8.2549% | |
| -11.7212% | |
| -68.797% | |
| -228.5164% | |
| -356.6835% | |
| -284.0491% | |
| 47.1644% | |
| 12.0741% | |
| 44.0267% | |
| 25.7672% | |
| 17.5289% | |
| -2.5121% | |
| -21.9613% | |
| -19.3022% | |
| 1.4746% | |
| 28.1915% | |
| 26.1379% | |
| 29.0098% | |
| 25.0436% | |
| 7.951% | |
| -3.6737% | |
| -5.5917% | |
| 2.0477% | |
| -11.546% | |
| -5.6504% | |
| -38.228% | |
| -40.1996% | |
| -17.1444% | |
| -3.0601% | |
| 44.1182% | |
| 44.7511% | |
| 47.2736% | |
| 42.5659% | |
| 14.6413% | |
| -28.9847% | |
| -296.2861% | |
| -841.4937% | |
| -3,787.9091% | |
| -951.6423% | |
| 38.4804% | |
| 75.3081% | |
| 94.2873% | |
| 69.4811% | |
| -81.924% | |
| -79.6237% | |
| -82.7586% | |
| 58.9147% | |
| 55% | |
| 51.2397% | |
| 53.6% | |
| -12.1739% | |
| -5.2632% | |
| -10% | |
| -20.1923% | |
| -21.0526% | |
| -21.2766% |